“Is the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma?” (2013) Journal of Cancer Research Updates, 2(4), pp.  297–305. doi:10.6000/1929-2279.2013.02.04.8.